Described herein are novel compositions and methods of treatment addressing diseases such as neurodegenerative diseases, including prion diseases and Alzheimer's disease.
本文描述了一种新的组合物和治疗方法,用于治疗神经退行性疾病,包括朊病和阿尔茨海默病。
E3 UBIQUITIN LIGASE AGONISTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE E3 UBIQUITIN LIGASE AGONISTS, RELATED METHODS OF USE
申请人:FRED HUTCHINSON CANCER RESEARCH CENTER
公开号:US20210047278A1
公开(公告)日:2021-02-18
E3 ubiquitin ligase agonists, pharmaceutical compositions including the E3 ubiquitin ligase agonists, and related methods of use are described.
Described herein are novel compositions and methods of treatment addressing diseases such as neurodegenerative diseases, including prion diseases and Alzheimer's disease.
Synthesis, Structure-Activity Relationship (SAR) Studies on some 4-Aryl-4Hchromenes and Relationship between Lipophilicity and Antitumor Activity
作者:Ahmed El-Agrody、Essam A. E. H. Khattab、Ahmed Fouda
DOI:10.2174/1570180811666140623204655
日期:2014.10.1
Some 4-aryl-4H-chromenes 3a-h, 5a-g, 7a-g and 9a-g were obtained by reaction of 3-substituted phenol 1, 4, 6
and 8 with α-cyanocinnamonitrile derivatives 2. We explored the structure activity relationship (SAR) of 4-aryl-4Hchromenes
with modification at the 4- and 7-positions. The antitumor activity of the synthesized compounds was investigated
in comparison with the standard drugs Vinblastine and Doxorubicin using microculture tetrazolium (MTT) colorimetric assay.
Some compounds were found to have good in vitro antitumor activity. The structure-activity relationship (SAR) study
revealed that the antitumor activity of 4-aryl-4H-chromenes was significantly affected by the lipophilicity, the calculated Log
P value and the balance between 7-hydrophilic or hydrophobic substituent and hydrophobic substituent on the benzene ring at
4-position. The structures of the newly prepared compounds were confirmed by elemental analysis and spectral data.